Clinical Trial Update: uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating uPAR PET/CT and FDG PET/MRI for preoperative staging of bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Urinary Bladder Neoplasms | Phase 2 | Status: UNKNOWN